Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TYROBP |
| Upstream (Parents) |
|---|
| (<<) LY96 → TYROBP |
| (<<) TFEC → TYROBP |
| (<<) FCER1G → TYROBP |
| Downstream (Children) |
|---|
| TYROBP → CD53 (>>) |
| TYROBP → EIF4A1///CD68 (>>) |
| TYROBP → FGR (>>) |
| TYROBP → LILRB4 (>>) |
| TYROBP → CCR1 (>>) |
| TYROBP → LILRB1 (>>) |
| TYROBP → DPEP2 (>>) |
| TYROBP → IL21R (>>) |
| TYROBP → HK3 (>>) |
| TYROBP → STAP1 (>>) |
| TYROBP → CD33 (>>) |
| TYROBP → RENBP (>>) |
| TYROBP → CD52 (>>) |
| TYROBP → ZNF132 (>>) |
| TYROBP → MMP23A///MMP23B (>>) |
| TYROBP → CXorf21 (>>) |
| TYROBP → LILRB3 (>>) |
| TYROBP → YY1 (>>) |
| TYROBP → SPI1 (>>) |
| TYROBP → BTG3 (>>) |
| TYROBP → LY96 (>>) |
| TYROBP → BTK (>>) |
| TYROBP → LILRA6///LILRB3 (>>) |
| TYROBP → PKD2L1 (>>) |
| TYROBP → FCGR1C///FCGR1A (>>) |
| TYROBP → ITGB2 (>>) |
| TYROBP → ADORA3 (>>) |
| TYROBP → TFEC (>>) |
| TYROBP → LAPTM5 (>>) |
| TYROBP → FCER1G (>>) |
| TYROBP → HPCA (>>) |
| TYROBP → CD86 (>>) |
| TYROBP → ARHGDIB (>>) |
